Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

September 29, 2026

Conditions
Congestive Heart Failure
Interventions
DEVICE

ezCVP measurement

"* Measuring device: non-FDA-cleared patient monitor (740E, Zoe Medical, MA, US), which has software to measure ezCVP.~* Sensor: an FDA-cleared pulse oximeter sensor for adults (K012891: DS-100A, Nellcor, CA, US).~* Cuff: an FDA-cleared NIBP cuff for adults (K080342: YP-713T, YP-714T or TP-715T, Nihon Kohden Corporation, Tokyo, Japan)."

Trial Locations (2)

94304

Veterans Affairs Hospital, Palo Alto

94305

Stanford Medical Center, Stanford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nihon Kohden

INDUSTRY

NCT05441696 - Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients | Biotech Hunter | Biotech Hunter